How 217 Pediatric Intensivists Manage Anemia at PICU Discharge: Online Responses to an International Survey.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 29 3 2020
medline: 7 1 2021
entrez: 29 3 2020
Statut: ppublish

Résumé

To describe the management of anemia at PICU discharge by pediatric intensivists. Self-administered, online, scenario-based survey. PICUs in Australia/New Zealand, Europe, and North America. Pediatric intensivists. None. Respondents were asked to report their decisions regarding RBC transfusions, iron, and erythropoietin prescription to children ready to be discharged from PICU, who had been admitted for hemorrhagic shock, cardiac surgery, craniofacial surgery, and polytrauma. Clinical and biological variables were altered separately in order to assess their effect on the management of anemia. Two-hundred seventeen responses were analyzed. They reported that the mean (± SEM) transfusion threshold was a hemoglobin level of 6.9 ± 0.09 g/dL after hemorrhagic shock, 7.6 ± 0.10 g/dL after cardiac surgery, 7.0 ± 0.10 g/dL after craniofacial surgery, and 7.0 ± 0.10 g/dL after polytrauma (p < 0.001). The most important increase in transfusion threshold was observed in the presence of a cyanotic heart disease (mean increase ranging from 1.80 to 2.30 g/dL when compared with baseline scenario) or left ventricular dysfunction (mean increase, 1.41-2.15 g/dL). One third of respondents stated that they would not prescribe iron at PICU discharge, regardless of the hemoglobin level or the baseline scenario. Most respondents (69.4-75.0%, depending on the scenario) did not prescribe erythropoietin. Pediatric intensivists state that they use restrictive transfusion strategies at PICU discharge similar to those they use during the acute phase of critical illness. Supplemental iron is less frequently prescribed than RBCs, and prescription of erythropoietin is uncommon. Optimal management of post-PICU anemia is currently unknown. Further studies are required to highlight the consequences of this anemia and to determine appropriate management.

Identifiants

pubmed: 32217901
doi: 10.1097/PCC.0000000000002307
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e342-e353

Commentaires et corrections

Type : CommentIn

Auteurs

Pierre Demaret (P)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, CHC, Liège, Belgium.
Univ. Lille, EA 2694 - Santé Publique: épidémiologie et qualité des soins, F-59000 Lille, France.

Oliver Karam (O)

Division of Pediatric Critical Care Medicine, Children's Hospital of Richmond at VCU, Richmond, VA.

Julien Labreuche Bst (J)

Univ. Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.

Fabrizio Chiusolo (F)

Anesthesia and Critical Care, Bambino Gesù Children's Hospital, Rome, Italy.

Juan Mayordomo Colunga (J)

Sección de Cuidados Intensivos Pediátricos, Área de Gestión Clínica de Pediatría, Hospital Universitario Central de Asturias, Oviedo, Spain.
CIBER-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Simon Erickson (S)

Division of Pediatric Critical Care, Princess Margaret Hospital, Perth, WA, Australia.

Marianne E Nellis (ME)

Pediatric Critical Care Medicine, Department of Pediatrics, NY Presbyterian Hospital - Weill Cornell Medicine, New York, NY.

Marie-Hélène Perez (MH)

Pediatric Intensive Care Unit, Department of Pediatrics, University Hospital of Lausanne, Lausanne, Switzerland.

Samiran Ray (S)

Pediatric Intensive Care Unit, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom.

Marisa Tucci (M)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, Sainte-Justine Hospital and Université de Montréal, Montreal, QC, Canada.

Ariane Willems (A)

Pediatric Intensive Care Unit, Department of Intensive Care, Leiden Universitair Medisch Centrum, Leiden, The Netherlands.

Alain Duhamel (A)

Univ. Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France.

Frédéric Lebrun (F)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, CHC, Liège, Belgium.

Isabelle Loeckx (I)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, CHC, Liège, Belgium.

André Mulder (A)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, CHC, Liège, Belgium.

Stéphane Leteurtre (S)

Univ. Lille, EA 2694 - Santé Publique: épidémiologie et qualité des soins, F-59000 Lille, France.
CHU Lille, Pediatric Intensive Care Unit, CHU Lille, F-59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH